Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes

INTRODUCTION: This randomized, double-blind, placebo-controlled, single and multiple ascending-dose study evaluated the pharmacodynamic effects and safety/tolerability of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes. METHODS: Patients (N = 116) discont...

Descripción completa

Detalles Bibliográficos
Autores principales: Sha, Sue, Devineni, Damayanthi, Ghosh, Atalanta, Polidori, David, Hompesch, Marcus, Arnolds, Sabine, Morrow, Linda, Spitzer, Heike, Demarest, Keith, Rothenberg, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148334/
https://www.ncbi.nlm.nih.gov/pubmed/25166023
http://dx.doi.org/10.1371/journal.pone.0105638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148334/
https://www.ncbi.nlm.nih.gov/pubmed/25166023
http://dx.doi.org/10.1371/journal.pone.0105638

Ejemplares similares